KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

Imax (IMAX) EBIAT (2016 - 2025)

Imax's EBIAT history spans 16 years, with the latest figure at $2.5 million for Q4 2025.

  • For Q4 2025, EBIAT fell 78.87% year-over-year to $2.5 million; the TTM value through Dec 2025 reached $45.5 million, up 25.43%, while the annual FY2025 figure was $45.5 million, 39.21% up from the prior year.
  • EBIAT for Q4 2025 was $2.5 million at Imax, down from $22.6 million in the prior quarter.
  • Across five years, EBIAT topped out at $22.6 million in Q3 2025 and bottomed at -$12.0 million in Q1 2022.
  • The 5-year median for EBIAT is $3.8 million (2022), against an average of $3.0 million.
  • The largest YoY upside for EBIAT was 392.91% in 2023 against a maximum downside of 269.15% in 2023.
  • A 5-year view of EBIAT shows it stood at $627000.0 in 2021, then skyrocketed by 316.75% to $2.6 million in 2022, then crashed by 269.15% to -$4.4 million in 2023, then surged by 370.34% to $11.9 million in 2024, then tumbled by 78.87% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for IMAX's EBIAT are $2.5 million (Q4 2025), $22.6 million (Q3 2025), and $12.2 million (Q2 2025).